132 related articles for article (PubMed ID: 17958742)
1. Upregulation of protein S by progestins.
Hughes Q; Watson M; Cole V; Sayer M; Baker R; Staton J
J Thromb Haemost; 2007 Nov; 5(11):2243-9. PubMed ID: 17958742
[TBL] [Abstract][Full Text] [Related]
2. The transcriptional activity of progestins used in contraception and menopausal hormone therapy via progesterone receptor A is dependent on the density of the receptor.
Cartwright M; Toit RL; Africander D
Biochem Biophys Res Commun; 2023 Jan; 639():70-76. PubMed ID: 36470074
[TBL] [Abstract][Full Text] [Related]
3. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor isoform ratios influence the transcriptional activity of progestins via the progesterone receptor.
Cartwright M; Louw-du Toit R; Jackson H; Janse van Vuuren M; Africander D
J Steroid Biochem Mol Biol; 2023 Sep; 232():106348. PubMed ID: 37315868
[TBL] [Abstract][Full Text] [Related]
5. Progestin isoforms provide different levels of protein S expression in HepG2 cells.
Kozuka T; Tamura S; Kawamura N; Nakata Y; Hasebe R; Makiyama A; Takagi Y; Murata M; Mizutani N; Takagi A; Kojima T
Thromb Res; 2016 Sep; 145():40-5. PubMed ID: 27447084
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of progestin- and estrogen-responsive promoters by 19-nor progestins in African Green Monkey Kidney CV1 cells.
Pasapera AM; Gutiérrez-Sagal R; García-Becerra R; Ulloa-Aguirre A; Savouret JF
Endocrine; 2001 Dec; 16(3):217-25. PubMed ID: 11954666
[TBL] [Abstract][Full Text] [Related]
7. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.
Diep CH; Charles NJ; Gilks CB; Kalloger SE; Argenta PA; Lange CA
Cell Cycle; 2013 May; 12(9):1433-49. PubMed ID: 23574718
[TBL] [Abstract][Full Text] [Related]
9. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
10. Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 (insulin-like growth factor binding protein-1) in human endometrial stromal cells.
Gao J; Mazella J; Tang M; Tseng L
Mol Endocrinol; 2000 Dec; 14(12):1954-61. PubMed ID: 11117526
[TBL] [Abstract][Full Text] [Related]
11. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.
Wei LL; Hawkins P; Baker C; Norris B; Sheridan PL; Quinn PG
Mol Endocrinol; 1996 Nov; 10(11):1379-87. PubMed ID: 8923464
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
Faivre EJ; Daniel AR; Hillard CJ; Lange CA
Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
[TBL] [Abstract][Full Text] [Related]
13. Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.
Diep CH; Knutson TP; Lange CA
Mol Cancer Res; 2016 Feb; 14(2):141-62. PubMed ID: 26577046
[TBL] [Abstract][Full Text] [Related]
14. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
Diep CH; Ahrendt H; Lange CA
Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
[TBL] [Abstract][Full Text] [Related]
15. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
[TBL] [Abstract][Full Text] [Related]
16. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
17. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
[TBL] [Abstract][Full Text] [Related]
18. Regulation of progesterone receptor messenger ribonucleic acid by progestin in human endometrial stromal cells.
Tseng L; Zhu HH
Biol Reprod; 1997 Dec; 57(6):1360-6. PubMed ID: 9408241
[TBL] [Abstract][Full Text] [Related]
19. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D; Kumar NS; Wolf DM; Leslie KK
Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
[TBL] [Abstract][Full Text] [Related]
20. The anti-progestin RU486 stabilizes the progestin-induced fatty acid synthetase mRNA but does not stimulate its transcription.
Chalbos D; Galtier F; Emiliani S; Rochefort H
J Biol Chem; 1991 May; 266(13):8220-4. PubMed ID: 2022639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
